𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer

✍ Scribed by Patricia L Judson; C Blair Harkness; Matthew P Boente; Levi S Downs Jr.; Peter A Argenta; Linda F Carson

Book ID
113959273
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
89 KB
Volume
93
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II and pharmacodynamic study of
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d